Life-extending drug for ovarian cancer made available in Europe
Cancer patients in Europe can now receive a life-extending drug invented and developed by scientists…
Browsing: ovarian cancer
Repurposing inhibitors may provide new treatment approach for ovarian cancer
Wistar researchers have found rationale for repurposing a class of antitumour compounds called HDAC inhibitors,…
Potential for personalised immunotherapy extended to large variety of cancers
A new study shows that ovarian cancer, which has proved resistant to currently available immunotherapies,…
AACR 2018: Chlamydia infection is associated with increased risk of ovarian cancer
An antibody that is present in the blood of women previously infected with the sexually…
New mutation linked to ovarian cancer can be passed down through father
A newly identified mutation, passed down through the X-chromosome, is linked to earlier onset of…
A new blood test can detect eight different cancers in their early stages
Peter Gibbs, Walter and Eliza Hall Institute Researchers have developed a blood test that can…
Decoding the molecular mechanisms of ovarian cancer progression
Ovarian cancer is the most lethal gynaecologic malignancy in the United States, resulting in an…
Many pelvic tumours in women may have common origin in fallopian tubes
Most – and possibly all – ovarian cancers start, not in ovaries, but instead in…
Mystery of BRCA in breast cancer risk solved, 20 years after its discovery
More than 20 years after scientists revealed that mutations in the BRCA1 gene predispose women…
ESMO 2017: Patients feel psycho-social impact of chemo more acutely than physical side effects
The preliminary results of a study presented at the ESMO 2017 Congress in Madrid show…